Radiation Therapy Fractionation for Basal Cell Carcinoma

Introduction to Radiation Therapy

The National Comprehensive Cancer Network recommends hypofractionated regimens (44-55 Gy in 10-20 fractions) for basal cell carcinoma requiring radiation therapy, offering equivalent tumor control to conventional fractionation with superior patient convenience 1, 2, 3

For tumors <2 cm, the National Comprehensive Cancer Network suggests 55 Gy in 20 fractions over 4 weeks as a standard hypofractionation with robust efficacy 1, 2, 3
For tumors ≥2 cm, 55 Gy in 20 fractions over 4 weeks is recommended 3
For larger lesions requiring higher total dose, 66 Gy in 33 fractions over 6-6.6 weeks is suggested 1, 2, 3

When cosmetic outcome is the priority, particularly for facial lesions, the National Comprehensive Cancer Network recommends 64 Gy in 32 fractions over 6-6.4 weeks for tumors <2 cm 1, 2, 3

For positive margins after surgery, 50 Gy in 20 fractions over 4 weeks or 60 Gy in 30 fractions over 6 weeks is recommended 1, 2

Field margins must account for beam characteristics, with 1-1.5 cm margins for tumors <2 cm and 1.5-2 cm margins for tumors ≥2 cm 1, 2
Electron beam requires wider margins than orthovoltage x-rays due to beam penumbra, though tighter margins can be used adjacent to critical structures with lead skin collimation 1, 2

Radiation therapy is absolutely contraindicated in basal cell nevus syndrome (Gorlin syndrome), xeroderma pigmentosum, and scleroderma and other connective tissue diseases 1, 2

The National Comprehensive Cancer Network advises against using hypofractionation indiscriminately on facial lesions, as it may result in inferior cosmetic outcomes 3
Wider margins are mandatory with electron beam compared to orthovoltage due to beam penumbra characteristics 1, 2
Radiation should not be used in patients under 60 years unless absolutely necessary, due to concerns about long-term sequelae including secondary malignancies and chronic tissue changes 3
Adequate bolus with electron beam is essential to achieve adequate surface dose and ensure tumor control 1, 2